Q&A: The status of the Access to Prescription Digital Therapeutics Act
The Access to Prescription Digital Therapeutics Act, initially introduced in the U.S. Senate in 2022 and reintroduced in March of this year, aims to amend the Social Security Act to provide Medicare and Medicaid coverage and reimbursement for prescription digital therapeutics. Jennifer Mathieu, senior vice president of professional and government affairs at the Academy of […]
Q&A: The status of the Access to Prescription Digital Therapeutics Act Read More »